Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26418208 | 0.87 | ERCC1 (0.47) | HPGDS1PR3CARM1PRMT6 | |
| SCHEMBL26422825 | 0.79 | ERCC1 (0.44) | HPGDS1PR3CARM1PRMT6 | |
| SCHEMBL26417663 | 0.77 | ALOX15 (0.40) | — | |
| SCHEMBL23417836 | 0.75 | ERCC1 (0.47) | HPGDS1PR3CARM1PRMT6 | |
| SCHEMBL17662449 | 0.74 | ELANE (0.40) | — | |
| SCHEMBL26428984 | 0.74 | ADRB2 (0.38) | — | |
| SCHEMBL26422908 | 0.73 | TOP2A (0.41) | HPGD | |
| SCHEMBL1456923 | 0.72 | P2RX7 (0.49) | HPGD | |
| SCHEMBL1456919 | 0.72 | P2RX7 (0.49) | HPGD | |
| SCHEMBL31036978 | 0.72 | P2RX7 (0.49) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | KLEO PHARMACEUTICALS, INC. | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128688-A1 | DIRECTED CONJUGATION TECHNOLOGIES | CD2BP2, CD2, CD47 | HPGD 4378/4885S1PR3 2576/4885CARM1 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.